Neuren Pharmaceuticals (NK9.F) Q1 2026 Earnings

25FebConfirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
0.01
0.21
0.41
0.62

Details

Expected EPS
0.007624625715
Actual EPS
0.066870791456
Surprise EPS
0.06
Surprise Percent
+777.04%

Description

Neuren Pharmaceuticals (NK9.F) has reported earnings of 0.066870791456 per share for Q1 2026.

0 Comments

Share your thoughts